| Literature DB >> 34996437 |
Mariam Mohsen Aly1, Manar Abdul-Waniss Mohammed Abdul-Aziz2, Marwa Aly Elchaghaby3.
Abstract
OBJECTIVES: The goal of the current study was to evaluate the relative frequency of oral and maxillofacial pathological lesions among Egyptian children.Entities:
Keywords: Children; Frequency; Oral maxillofacial; Pathological lesions
Mesh:
Year: 2022 PMID: 34996437 PMCID: PMC8742446 DOI: 10.1186/s12903-021-02037-6
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Demographic data of the study sample
| Demographic data | N | % |
|---|---|---|
| 0–5 years | 81 | 7.3 |
| 6–10 years | 280 | 25.3 |
| 11–15 years | 412 | 37.2 |
| 16–18 years | 335 | 30.2 |
| Female | 559 | 50.5 |
| Male | 549 | 49.5 |
| Gingiva | 354 | 31.9 |
| Mandible | 303 | 27.3 |
| Maxilla | 262 | 23.6 |
| Lip | 81 | 7.3 |
| Buccal mucosa | 39 | 3.5 |
| Palate | 31 | 2.8 |
| Tongue | 23 | 2.1 |
| Floor of the mouth | 15 | 1.4 |
| 1999–2003 | 114 | 10.3 |
| 2004–2008 | 152 | 13.7 |
| 2009–2013 | 293 | 26.4 |
| 2014–2019 | 549 | 49.5 |
Distribution of study sample among categories with the most common lesion of each category
| Categories | Subcategories | N | % | Most common lesion | N | % |
|---|---|---|---|---|---|---|
| Allergies and immunologic disease | 1 | 0.1 | Sarcoidosis | 1 | 0.1 | |
| Bone pathology | Benign | 10 | 0.9 | Desmoplastic fibroma | 3 | 0.3 |
| Giant cell lesion | 49 | 4.4 | Central giant cell lesions | 41 | 3.7 | |
| Malignant | 4 | 0.4 | Osteosarcoma | 3 | 0.3 | |
| Fibro osseous | 38 | 3.4 | Ossifying fibroma | 27 | 2.4 | |
| Dermatologic diseases | 2 | 0.2 | White sponge nevus | 1 | 0.1 | |
| Lichen planus | 1 | 0.1 | ||||
| Developmental Non-odontogenic cyst | 11 | 1 | Incisive canal cyst | 6 | 0.5 | |
| Epithelial pathology | Benign | 6 | 0.5 | Squamous cell papilloma | 4 | 0.4 |
| Reactive | 2 | 0.2 | Verruca vulgaris | 1 | 0.1 | |
| Traumatic ulcer | 1 | 0.1 | ||||
| Odontogenic cysts | Developmental | 93 | 8.4 | Dentigerous cyst | 38 | 3.4 |
| Odontogenic KeratoCyst | 35 | 3.2 | ||||
| Inflammatory | 213 | 19.2 | Inflammatory radicular cyst | 208 | 18.8 | |
| Benign odontogenic tumor | Epithelial | 53 | 4.8 | Ameloblastoma | 31 | 2.8 |
| Mesenchymal | 19 | 1.7 | Odontogenic myxoma | 8 | 0.7 | |
| Odontogenic fibroma | 7 | 0.6 | ||||
| Mixed | 25 | 2.3 | Odontoma | 16 | 1.4 | |
| Periodontal diseases | 22 | 2 | Gingival fibromatosis | 14 | 1.3 | |
| Periapical diseases | 47 | 4.2 | Periapical granuloma | 44 | 4 | |
| Salivary gland pathology | Benign | 5 | 0.5 | Pleomorphic adenoma | 5 | 0.5 |
| Malignant | 5 | 0.5 | Mucoepidermoid carcinoma | 4 | 0.4 | |
| Reactive | 61 | 5.5 | Mucous extravasation cyst (mcocele) | 56 | 5.1 | |
| Soft tissue tumors | Benign | 35 | 3.2 | Hemangioma | 9 | 0.8 |
| Malignant | 10 | 0.9 | Lymphoma | 5 | 0.5 | |
| Reactive | 397 | 35.8 | Pyogenic granuloma | 160 | 14.4 | |
| Peripheral giant cell granuloma | 99 | 8.9 | ||||
| Irritational fibroma | 90 | 8.1 | ||||
| Peripheral ossifying fibroma | 38 | 3.4 | ||||
| Total number of lesions | 1108 | 100 | 956 | 86.3 |
Distribution of the most common 20 lesions in the study
| Most common 20 lesions | N | The percentage from the total population (%) |
|---|---|---|
| Inflammatory radicular cyst | 208 | 18.8 |
| Pyogenic granuloma | 160 | 14.4 |
| Peripheral giant cell granuloma | 99 | 8.9 |
| Irritational fibroma | 90 | 8.1 |
| Mucocele (mucous extravasation cyst) | 56 | 5.1 |
| Periapical granuloma | 44 | 4.0 |
| Central giant cell lesion | 41 | 3.7 |
| Dentigerous cyst | 38 | 3.4 |
| Peripheral ossifying fibroma | 38 | 3.4 |
| Ameloblastoma | 31 | 2.8 |
| Odontogenic keratocyst | 30 | 2.7 |
| Ossifying fibroma | 27 | 2.4 |
| Odontoma | 16 | 1.4 |
| Gingival fibromatosis | 12 | 1.1 |
| Gorlin's syndrome | 12 | 1.1 |
| Unicystic ameloblastoma | 11 | 1.0 |
| F. fibrous dysplasia | 9 | 0.8 |
| Hemangioma | 9 | 0.8 |
| Adenomatoid odontogenic tumor | 7 | 0.6 |
| Odontogenic fibroma | 7 | 0.6 |
Age distribution among study categories
| Categories | Age distribution | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0–5 years | 6–10 years | 11–15 years | 16–18 years | ||||||
| N | % | N | % | N | % | N | % | ||
| Allergies and immunologic disease | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | |
| Bone pathology | 5 | 5.0 | 29 | 28.7 | 42 | 41.6 | 25 | 24.8 | |
| Dermatologic diseases, immunologic | 0 | 0.0 | 0 | 0.0 | 1 | 50.0 | 1 | 50.0 | |
| Developmental, non-odontogenic cyst | 2 | 18.2 | 3 | 27.3 | 5 | 45.5 | 1 | 9.1 | |
| Epithelial pathology | 0 | 0.0 | 5 | 62.5 | 0 | 0.0 | 3 | 37.5 | |
| Odontogenic cysts | 4 | 1.3 | 79 | 25.8 | 113 | 36.9 | 110 | 35.9 | |
| Benign odontogenic tumor | 5 | 5.2 | 7 | 7.2 | 45 | 46.4 | 40 | 41.2 | |
| Periodontal diseases | 2 | 9.1 | 6 | 27.3 | 9 | 40.9 | 5 | 22.7 | |
| Periapical diseases | 4 | 8.5 | 7 | 14.9 | 19 | 40.4 | 17 | 36.2 | |
| Salivary gland pathology | 8 | 11.3 | 31 | 43.7 | 12 | 16.9 | 20 | 28.2 | |
| Soft tissue tumors | 51 | 11.5 | 113 | 25.6 | 165 | 37.3 | 113 | 25.6 | |
P < 0.05 indicated a statistically significant difference and they are shown in bold
Sex distribution among study categories
| Categories | Sex distribution | ||||
|---|---|---|---|---|---|
| Male | Female | ||||
| N | % | N | % | ||
| Allergies and immunologic disease | 1 | 100.0 | 0 | 0.0 | |
| Bone pathology | 49 | 48.5 | 52 | 51.5 | |
| Dermatologic diseases, immunologic | 0 | 0.0 | 2 | 100.0 | |
| Developmental, non-odontogenic cyst | 6 | 54.5 | 5 | 45.5 | |
| Epithelial Pathology | 5 | 62.5 | 3 | 37.5 | |
| Odontogenic cysts | 170 | 55.6 | 136 | 44.4 | |
| Odontogenic tumor Benign | 56 | 57.7 | 41 | 42.3 | |
| Periodontal diseases | 9 | 40.9 | 13 | 59.1 | |
| Periapical diseases | 23 | 48.9 | 24 | 51.1 | |
| Salivary gland pathology | 23 | 32.4 | 48 | 67.6 | |
| Soft tissue tumors | 207 | 46.8 | 235 | 53.2 | |
P < 0.05 indicated a statistically significant difference and they are shown in bold
Location distribution among study categories
| Categories | Location distribution | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Lip | Buccal mucosa | Tongue | Palate | Mouth floor | Gingiva alv.ridge | man | max | ||
| Allergies and immunologic disease | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (1) 100.0% | (0) 0.0% | |
| Bone pathology | (0) 0.0% | (0) 0.0% | (0) 0.0% | (1) 1.0% | (0) 0.0% | (2) 2.0% | (50) 49.5% | (48) 47.5% | |
| Dermatologic diseases, immunologic | (0) 0.0% | (2) 100.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | |
| Developmental, non-odontogenic cyst | (1) 9.1% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (2) 18.2% | (0) 0.0% | (1) 9.1% | (7) 63.6% | |
| Epithelial pathology | (2) 25.0% | (1) 12.5% | (3) 37.5% | (1) 12.5% | (0) 0.0% | (1) 12.5% | (0) 0.0% | (0) 0.0% | |
| Odontogenic cysts | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (2) 0.7% | (157) 51.3% | (147) 48.0% | |
| Odontogenic tumor Benign | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (3) 3.1% | (63) 64.9% | (61) 32.0% | |
| Periodontal diseases | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (22) 100.0% | (0) 0.0% | (0) 0.0% | |
| Periapical diseases | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (0) 0.0% | (24) 51.1% | (23) 48.9% | |
| Salivary gland pathology | (49) 69.0% | (4) 5.6% | (0) 0.0% | (7) 9.9% | (10) 14.1% | (0) 0.0% | (1) 1.4% | (0) 0.0% | |
| Soft tissue tumors | (29) 6.6% | (32) 7.2% | (20) 4.5% | (22) 5.0% | (3) 0.7% | (324) 73.3% | (6) 1.4% | (6) 1.4% | |
P < 0.05 indicated a statistically significant difference and they are shown in bold
Distribution and demographic data of the malignant lesions in the study
| Category | Diagnosis | Age | Sex | Location | N (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–5 | 6–10 | 11–15 | 16–18 | Male | Female | Palate | Mouth floor | Gingiva alv ridge | man | max | |||
| Malignant bone pathology | Osteosarcoma | 0 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 3 | 3 (15.8%) |
| Malignant bone pathology | Chondrosarcoma | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 (5.3%) |
| Malignant salivary gland pathology | Mucoepidermoid carcinoma | 0 | 3 | 0 | 1 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 4 (21.1%) |
| Malignant salivary gland pathology | Adenocarcinoma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Malignant soft tissue tumors | Lymphoma | 3 | 2 | 0 | 0 | 2 | 3 | 0 | 1 | 1 | 1 | 2 | 5 (26.3%) |
| Malignant soft tissue tumors | Plasmacytoma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Malignant soft tissue tumors | Embryonal rhabdomyo sarcoma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Malignant soft tissue tumors | Fibrosarcoma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Malignant soft tissue tumors | Hemangio endothelioma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Malignant soft tissue tumors | Alveolar soft tissue sarcoma | 1 | 1 | 1 | 1 (5.3%) | ||||||||
| Total malignant tumors | 4 | 7 | 3 | 5 | 10 | 9 | 4 | 1 | 4 | 4 | 6 | 19 (100%) | |